People · Operator
Named in public records as an officer, director or promoter · active 2010–2021 · Biotech / Pharma, Biotechnology, Other Energy
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Greenlight Biosciences Inc. | — | Biotech / Pharma | Series D+ | $179.4M | $3.9B | 2013 |
| Iterative Scopes, Inc. | — | Biotechnology | Series D+ | $172.1M | $3.6B | 2021 |
| Axcella Health Inc. | — | Biotechnology | Series C | $92.8M | $105.5M | 2015 |
| LS9, Inc. | — | Other Energy | Series B | $30.0M | $348.1M | 2010 |
Charles Cooney at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Charles Cooney on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Noubar Afeyan | 2 | 9 |
| Peter Barton Hutt | 1 | 14 |
| Vinod Khosla | 1 | 12 |
| Matthew Walker | 1 | 11 |
| Michael Liang | 1 | 9 |
| Jonathan Fleming | 1 | 9 |
| PETER MORAN | 1 | 9 |
| Lonne Jaffe | 1 | 8 |
| Jason Dinges | 1 | 8 |
| David Furneaux | 1 | 8 |
| Robert Crane | 1 | 7 |
| Peter Nieh | 1 | 7 |
| Ganesh Kishore | 1 | 7 |
| Andrey Zarur | 1 | 6 |
| Eric O'Brien | 1 | 6 |
| Neil Renninger | 1 | 4 |
| Charles L. Cooney | 1 | 4 |
| Robert Connelly | 1 | 4 |
| Martha Schlicher | 1 | 4 |
| Nan Li | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.